Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-25-033662

Options or other derivatives

  • Chief Executive Officer acquired 650,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Spoor Johan M. Chief Executive Officer 2025-03-03 Grant or award · Stock option (right to buy) +650,000 650,000 D
Loading xslF345X05/ownership.xml…